Fonar Corporation

17.07-0.0700-0.41%Vol 16.25K1Y Perf -22.04%
Sep 24th, 2021 16:00 DELAYED
BID17.05 ASK17.32
Open17.15 Previous Close17.14
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     63.77
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     62.74
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
8.78 
Earnings Rating
Neutral
Market Cap111.88M 
Earnings Date
27th Sep 2021
Alpha-0.01 Standard Deviation0.11
Beta1.00 

Today's Price Range

17.0717.39

52W Range

16.5122.89

5 Year PE Ratio Range

4.7012.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.41%
1 Month
2.34%
3 Months
-2.68%
6 Months
-8.13%
1 Year
-22.04%
3 Years
-31.03%
5 Years
-15.75%
10 Years
875.43%

TickerPriceChg.Chg.%
FONR17.07-0.0700-0.41
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.54-
Q02 2021-0.44-
Q01 2021-0.36-
Q04 2020-0.08-
Q03 2020-0.18-
Q02 2020-0.44-
Q01 2020-0.47-
Q04 2019-0.66-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date27th Sep 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume16.25K
Shares Outstanding6.55M
Shares Float6.35M
Trades Count129
Dollar Volume1.14M
Avg. Volume36.57K
Avg. Weekly Volume17.10K
Avg. Monthly Volume18.46K
Avg. Quarterly Volume36.51K

Fonar Corporation (NASDAQ: FONR) stock closed at 17.07 per share at the end of the most recent trading day (a -0.41% change compared to the prior day closing price) with a volume of 16.25K shares and market capitalization of 111.88M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 424 people. Fonar Corporation CEO is Timothy R. Damadian.

The one-year performance of Fonar Corporation stock is -22.04%, while year-to-date (YTD) performance is -1.67%. FONR stock has a five-year performance of -15.75%. Its 52-week range is between 16.51 and 22.89, which gives FONR stock a 52-week price range ratio of 8.78%

Fonar Corporation currently has a PE ratio of 12.00, a price-to-book (PB) ratio of 0.82, a price-to-sale (PS) ratio of 1.69, a price to cashflow ratio of 5.70, a PEG ratio of 2.32, a ROA of 5.15%, a ROC of 5.79% and a ROE of 6.97%. The company’s profit margin is 17.60%, its EBITDA margin is 21.20%, and its revenue ttm is $65.23 Million , which makes it $9.95 revenue per share.

Of the last four earnings reports from Fonar Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Fonar Corporation’s next earnings report date is 27th Sep 2021.

The consensus rating of Wall Street analysts for Fonar Corporation is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Fonar Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fonar Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fonar Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 11.32, ATR14 : 0.36, CCI20 : -3.27, Chaikin Money Flow : 0.07, MACD : 0.01, Money Flow Index : 32.50, ROC : -2.23, RSI : 49.62, STOCH (14,3) : 35.24, STOCH RSI : 0.71, UO : 40.38, Williams %R : -64.76), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fonar Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.

CEO: Timothy R. Damadian

Telephone: +1 631 694-2929

Address: 110 Marcus Drive, Melville 11747, NY, US

Number of employees: 424

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

52%48%

Bearish Bullish

64%36%

News

Stocktwits